The inside story. Physicians' views on digital ano-rectal examination for anal cancer screening of HIV positive men who have sex with men

Jason Ong, Marcus Y Chen, Meredith Temple-Smith, Sandra Walker, Jennifer F Hoy, Ian John Woolley, Andrew Grulich, Christopher Kit Fairley

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)

Abstract

OBJECTIVE: Anal cancer is relatively common amongst HIV positive men who have sex with men (MSM), but little is known about the anal cancer screening practices of HIV physicians, and whether digital ano-rectal examination (DARE) is utilized for this. To determine the practice of anal cancer screening among HIV physicians, and to identify any barriers for implementing DARE as a method for anal cancer screening. METHODS: 36 physicians from a sexual health centre, 2 tertiary hospital infectious diseases outpatient clinics, and 2 general practices completed a questionnaire on their practice of anal cancer screening amongst HIV positive MSM. Physicians were asked about their confidence in using DARE for anal cancer screening, and whether they perceived barriers to implementing this in their clinic. RESULTS: Most physicians (86 , 95 CI: 71-95) thought that anal cancer screening was important, but only 22 (95 CI: 10-39) were currently screening. Reasons for not screening were the absence of guidelines (87 , 95 CI: 60-98), lack of time (47 , 95 CI: 30-65), and concern about patient acceptability of DARE (32 , 95 CI: 17-51). Whilst 67 (95 CI: 49-81) of physicians felt confident in performing a DARE, only 22 (95 CI: 10-39) were confident in recognizing anal cancer using DARE. CONCLUSION: Although HIV physicians were aware of the need for anal cancer screening among the HIV + MSM population, few were routinely screening. If DARE were to be incorporated into routine HIV care, guidelines recommending screening and up-skilling of HIV physicians to recognize anal cancer are needed.
Original languageEnglish
Pages (from-to)188 - 191
Number of pages4
JournalJournal of Medical Screening
Volume20
Issue number4
DOIs
Publication statusPublished - 2013

Cite this

@article{6e752cc18c354bcf850da5fd3a513556,
title = "The inside story. Physicians' views on digital ano-rectal examination for anal cancer screening of HIV positive men who have sex with men",
abstract = "OBJECTIVE: Anal cancer is relatively common amongst HIV positive men who have sex with men (MSM), but little is known about the anal cancer screening practices of HIV physicians, and whether digital ano-rectal examination (DARE) is utilized for this. To determine the practice of anal cancer screening among HIV physicians, and to identify any barriers for implementing DARE as a method for anal cancer screening. METHODS: 36 physicians from a sexual health centre, 2 tertiary hospital infectious diseases outpatient clinics, and 2 general practices completed a questionnaire on their practice of anal cancer screening amongst HIV positive MSM. Physicians were asked about their confidence in using DARE for anal cancer screening, and whether they perceived barriers to implementing this in their clinic. RESULTS: Most physicians (86 , 95 CI: 71-95) thought that anal cancer screening was important, but only 22 (95 CI: 10-39) were currently screening. Reasons for not screening were the absence of guidelines (87 , 95 CI: 60-98), lack of time (47 , 95 CI: 30-65), and concern about patient acceptability of DARE (32 , 95 CI: 17-51). Whilst 67 (95 CI: 49-81) of physicians felt confident in performing a DARE, only 22 (95 CI: 10-39) were confident in recognizing anal cancer using DARE. CONCLUSION: Although HIV physicians were aware of the need for anal cancer screening among the HIV + MSM population, few were routinely screening. If DARE were to be incorporated into routine HIV care, guidelines recommending screening and up-skilling of HIV physicians to recognize anal cancer are needed.",
author = "Jason Ong and Chen, {Marcus Y} and Meredith Temple-Smith and Sandra Walker and Hoy, {Jennifer F} and Woolley, {Ian John} and Andrew Grulich and Fairley, {Christopher Kit}",
year = "2013",
doi = "10.1177/0969141313515463",
language = "English",
volume = "20",
pages = "188 -- 191",
journal = "Journal of Medical Screening",
issn = "0969-1413",
publisher = "SAGE Publications Ltd",
number = "4",

}

The inside story. Physicians' views on digital ano-rectal examination for anal cancer screening of HIV positive men who have sex with men. / Ong, Jason; Chen, Marcus Y; Temple-Smith, Meredith; Walker, Sandra; Hoy, Jennifer F; Woolley, Ian John; Grulich, Andrew; Fairley, Christopher Kit.

In: Journal of Medical Screening, Vol. 20, No. 4, 2013, p. 188 - 191.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - The inside story. Physicians' views on digital ano-rectal examination for anal cancer screening of HIV positive men who have sex with men

AU - Ong, Jason

AU - Chen, Marcus Y

AU - Temple-Smith, Meredith

AU - Walker, Sandra

AU - Hoy, Jennifer F

AU - Woolley, Ian John

AU - Grulich, Andrew

AU - Fairley, Christopher Kit

PY - 2013

Y1 - 2013

N2 - OBJECTIVE: Anal cancer is relatively common amongst HIV positive men who have sex with men (MSM), but little is known about the anal cancer screening practices of HIV physicians, and whether digital ano-rectal examination (DARE) is utilized for this. To determine the practice of anal cancer screening among HIV physicians, and to identify any barriers for implementing DARE as a method for anal cancer screening. METHODS: 36 physicians from a sexual health centre, 2 tertiary hospital infectious diseases outpatient clinics, and 2 general practices completed a questionnaire on their practice of anal cancer screening amongst HIV positive MSM. Physicians were asked about their confidence in using DARE for anal cancer screening, and whether they perceived barriers to implementing this in their clinic. RESULTS: Most physicians (86 , 95 CI: 71-95) thought that anal cancer screening was important, but only 22 (95 CI: 10-39) were currently screening. Reasons for not screening were the absence of guidelines (87 , 95 CI: 60-98), lack of time (47 , 95 CI: 30-65), and concern about patient acceptability of DARE (32 , 95 CI: 17-51). Whilst 67 (95 CI: 49-81) of physicians felt confident in performing a DARE, only 22 (95 CI: 10-39) were confident in recognizing anal cancer using DARE. CONCLUSION: Although HIV physicians were aware of the need for anal cancer screening among the HIV + MSM population, few were routinely screening. If DARE were to be incorporated into routine HIV care, guidelines recommending screening and up-skilling of HIV physicians to recognize anal cancer are needed.

AB - OBJECTIVE: Anal cancer is relatively common amongst HIV positive men who have sex with men (MSM), but little is known about the anal cancer screening practices of HIV physicians, and whether digital ano-rectal examination (DARE) is utilized for this. To determine the practice of anal cancer screening among HIV physicians, and to identify any barriers for implementing DARE as a method for anal cancer screening. METHODS: 36 physicians from a sexual health centre, 2 tertiary hospital infectious diseases outpatient clinics, and 2 general practices completed a questionnaire on their practice of anal cancer screening amongst HIV positive MSM. Physicians were asked about their confidence in using DARE for anal cancer screening, and whether they perceived barriers to implementing this in their clinic. RESULTS: Most physicians (86 , 95 CI: 71-95) thought that anal cancer screening was important, but only 22 (95 CI: 10-39) were currently screening. Reasons for not screening were the absence of guidelines (87 , 95 CI: 60-98), lack of time (47 , 95 CI: 30-65), and concern about patient acceptability of DARE (32 , 95 CI: 17-51). Whilst 67 (95 CI: 49-81) of physicians felt confident in performing a DARE, only 22 (95 CI: 10-39) were confident in recognizing anal cancer using DARE. CONCLUSION: Although HIV physicians were aware of the need for anal cancer screening among the HIV + MSM population, few were routinely screening. If DARE were to be incorporated into routine HIV care, guidelines recommending screening and up-skilling of HIV physicians to recognize anal cancer are needed.

UR - http://www.ncbi.nlm.nih.gov/pubmed/24307004

U2 - 10.1177/0969141313515463

DO - 10.1177/0969141313515463

M3 - Article

VL - 20

SP - 188

EP - 191

JO - Journal of Medical Screening

JF - Journal of Medical Screening

SN - 0969-1413

IS - 4

ER -